Clinical Trial Update: A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Completed Phase 2 trial comparing atezolizumab plus tiragolumab versus atezolizumab plus placebo as first-line treatment for PD-L1 positive head and neck squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED